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Objective: The femoropopliteal vein (FPV) graft has been used extensively for large-caliber vascular reconstructions. To
date, there have been no reports of anastomotic dehiscence or rupture leading to graft-associated hemorrhage (GAH). In
the present report, we review our experience with GAH from FPV grafts to determine the incidence of this problem, to
better understand the etiology, and to determine potential methods to prevent this complication.
Methods: All patients undergoing arterial reconstructions with FPV grafts were entered into a registry that included
demographics, operative details, complications, and follow-up information. Episodes of GAH that occurred during the
period from 1990 to 2004 were studied to determine etiologic factors and outcomes.
Results: During the study period, 574 FPV grafts were used for arterial reconstructions in 364 patients. GAH occurred
in 11 patients (3%). Onset of GAH ranged from 1 hour to 180 days after operation. The mean blood transfusion
requirement for GAHwas 10 4 units. In three patients, the etiology of GAHwas purely technical, resulting in a slipped
or “popped” tie from a large side branch. In eight patients, the etiology was due to graft disruption secondary to
uncontrolled infection and failure of anastomotic healing. Most of these patients were being treated for aortic graft
infection. Special risk factors for this complication included malnutrition, ongoing polymicrobial and fungal infections,
immunocompromised state, active cancer, steroid treatment, and ongoing graft contamination from gastrointestinal or
pharyngeal leaks. Outcomes included four deaths and one stroke.
Conclusions: GAH is a serious complication with high morbidity, mortality, and transfusion requirements. Although
technical problems are preventable, FPV grafts, like all biologic grafts, can develop disruption with GAH from ongoing
infection, especially in severely immunocompromised patients who are malnourished and have poor healing ability.
Strategies for prevention and alternative treatment modalities are appropriate in patients at high risk for GAH. (J Vasc
Surg 2005;42:667-72.)The femoropopliteal vein (FPV), or deep vein, has been
used extensively for arterial and venous reconstructions.1-9
Because of its large caliber and resistance to infection, most
of these grafts have been placed in reoperative and infected
fields involving large arteries. FPV grafts have proven to be
durable, with excellent long-term patency. To date, there
have been no reports of aneurysmal degeneration,6 anasto-
motic dehiscence, or rupture.
In our large experience with FPV grafts used for arterial
reconstructions at multiple anatomic sites, we have encoun-
tered occasional graft-associated hemorrhage (GAH) in the
postoperative period. GAHhas usually been caused by graft
disruption from uncontrolled infection or poor healing at
anastomoses. We have also, disappointingly, encountered
GAH from technical errors, usually related to poorly placed
ligatures on the large side branches of the FPV grafts. The
present report details our experience with GAH from FPV
grafts used for arterial reconstructions. We undertook this
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doi:10.1016/j.jvs.2005.06.002review to determine the incidence of this complication, to
better understand the etiology, and to determine potential
methods to prevent this problem.
METHODS
Study population. All arterial bypasses with FPV
grafts from 1990 to 2004 at the University of Texas South-
western Medical Center at Dallas and affiliated hospitals
(Zale Lipshy University Hospital, Dallas Veterans Affairs
Medical Center, and Parkland Memorial Hospital) were
retrospectively reviewed. These included aortoiliac, aorto-
femoral, brachiocephalic, carotid, visceral/renal, and lower-
extremity reconstructions. Venous reconstructions and ar-
teriovenous grafts for angioaccess were excluded. Data
were entered into a registry that included operative and
anesthesia records, hospital progress notes, graft microbi-
ology, and follow-up information.
Patients were followed at 3- to 4-month intervals the
first year after operation and at 6-month intervals thereaf-
ter. Episodes of GAH from FPV grafts were noted and
analyzed in further detail that included chart review, inter-
view with surgeons involved in the case, and review of
morbidity and mortality conference records. The GAH
episodes that were reviewed were classified as being techni-
cal or nontechnical in etiology.
Harvest and handling of FPV grafts. Details of the
FPV graft harvest and subsequent handling have been
published.10 Germane to this report, all branches of the
vein are ligated with silk ligatures. In contrast to handling
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tion to the deep vein wall. This is because many branches
have a thin wall at their origin that often extends onto the
caudad portion of the FPV.11 Close apposition of ligatures
at this site helps to buttress this thin area with adventitia.
In our previous experiences, when the FPV graft was
used in a nonreversed configuration, venous valves were
ablated with a valvulotome. We have subsequently encoun-
tered stenoses that later developed at valve sites and have
noted that routine passage of a valvulotome only partially
disrupts these large valves. Because of this, we now com-
pletely evert the vein graft and excise venous valves under
direct vision.
After the FPV grafts are harvested and prepared, they
are stored for 30 minutes to 2 hours in a preservation
solution consisting of Ringer’s lactate (1 L), heparin (5000
U), albumin (25 g), and papaverine (60 mg) at 4° C.
RESULTS
Over a 14-year period (1990 to 2004), 574 FPV grafts
were used for arterial reconstructions in 364 patients. Fol-
low-up ranged from 2 months to 96 months, with a mean
follow-up of 56 months. Among living patients, 95% re-
ceived complete follow-up; the remaining 5% were lost to
follow-up. Reconstructions were classified according to
anatomic sites (Table I). Most of these reconstructions
were performed in the aortofemoral or aortoiliac location.
When two FPV grafts were used to fashion an aortic recon-
struction, these were considered separately as individual
grafts (Table I).
GAH occurred in 11 patients (3%). Details of these
patients and their outcomes are shown in Tables II and III.
GAH occurred in six male and five female patients with a
mean age of 63 4 years. The overall incidence of GAH for
all FPV grafts was 1.9%. Onset of GAH varied from 1 hour
to 180 days after operation (Fig 1). By Kaplan-Meier
survival analysis, freedom from GAH was 97% at 6 months
and 96% thereafter for up to 5 years, with a standard error of
2%. The mean blood transfusion requirement for GAHwas
10  4 units (range, 4 to 17 units).
Technical problems leading to GAH occurred in three
patients (Table II). These episodes were all due to a slipped
or “popped” tie from a large side branch, and all occurred
within 12 hours of operation (Fig 1). Two of these patients
Table I. Total experience with femoropopliteal vein
grafts for arterial replacement
FPV graft reconstruction Grafts Patients
Aortoiliac/femoral 451 242
Visceral/renal 40 39
Carotid/brachiocephalic 36 36
Femorofemoral 32 32
Femoropopliteal 15 15
Total 574 364
FPV, Femoropopliteal vein.presented with cardiac arrest, and one had hypotension andan expanding, pulsatile thigh hematoma. All three patients
were rushed back to the operating room, where the bleed-
ing side branch was rapidly repaired. All three patients
survived without further complication.
Eight patients had GAH from graft disruption second-
ary to uncontrolled infection, failure of anastomotic heal-
ing, or both (Table III). Time to disruption was from 6 to
180 days (Fig 1). Six aortic reconstructions and two carotid
replacements were performed. The carotid replacements were
for patients with head and neck cancer. These patients were
generally malnourished and immunocompromised (Table
III). Mean serum albumen levels near the time of onset of
GAH were 2.0 0.8 mg/dL.
Among patients with aortic FPV reconstructions, four
developed anastomotic dehiscence that led to GAH (Fig
2), and two had perforation or “blow-out” at a single site of
an iliac or femoral limb. The perforations were approxi-
mately 1 cm in diameter with irregular borders. It was not
clear whether either of these perforations were the site of a
side branch ligature or were simply graft wall erosion (no
ligatures were found at the site of perforation).
Almost all aortic reconstructions had polymicrobial
infections with varying mixtures of gram-negative organ-
Fig 1. Graphic representation of postoperative time of onset of
graft-associated hemorrhage.
Fig 2. Large anastomotic false aneurysm at site of left iliac FPV
graft limb dehiscence from aorto-right femoral FPV graft. This site
was also contiguous with leak from duodenorraphy.isms, anaerobic bacteria, and fungal organisms (Table III).
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specifically cultured and yielded Escherichia coli, Pseudomonas
aeruginosa, and Enterococcus species.
Many of these patients had special risk factors that
predisposed them to ongoing infection and an immuno-
compromised state (Table III). These included metastatic
adenocarcinoma in the liver; treatment with high-dose
steroids, gold, and methotrexate for severe rheumatoid
arthritis; ongoing leak from a duodenorrhaphy in the pa-
tient with an aortoenteric fistula; severe malnutrition from
refusal of enteral and parenteral alimentation; head and
neck cancer; recent radiotherapy or chemotherapy, or both;
and a myeloproliferative disorder. Most had a prolonged
preoperative time interval between the time of diagnosis of
graft infection and definitive treatment with graft excision
and FPV replacement (Table III).
Four of these six patients died, two from sepsis and
multisystem organ dysfunction and two from exsanguina-
tion. The patient with metastatic liver cancer required high
above-knee amputation after ligation of the left limb of an
FPV graft aortofemoral bypass and subsequently died from
sepsis and proximal muscle ischemia.
Two patients had GAH from anastomotic dehiscence
after FPV graft replacement of the carotid artery for radical
head and neck surgery operations in which the carotid
artery was encased in tumor. One of these patients had
recurrent neck squamous cell carcinoma, and both were
alcoholic and malnourished. Despite coverage with pecto-
ralis major muscle flap, oropharyngeal leaks occurred in
both of these patients, and the vein grafts were bathed in
saliva. Both disruptions and episodes of GAH occurred at
about 1 week after operation. Both patients underwent emer-
gency operation and survived, but one had a major hemi-
spheric stroke after ligation of the FPV graft (Table III).
DISCUSSION
FPV GAH is a serious problem that led to four deaths,
one stroke, and one lower-extremity amputation in the 11
patients in this report. Fortunately, the overall incidence of
GAH is low, being 1.9% for all FPV grafts and 3.0% for all
patients. If one excludes technical causes of GAH, the
incidence due to ongoing infection and failure to heal is
1.4% of grafts and 2.2% of patients. The latter incidence is
a realistic expectation of outcomes from using the FPV
graft in hostile environments characterized by a reoperative
Table II. Patients with technical etiologies for graft-assoc
Age/Sex
FPV graft
reconstruction
Postoperative
time of GAH Prese
54 y/M Femoropopliteal bypass 6 hours Expand
hem
59 y/F Iliofemoral 1 hour Cardia
64 y/M Iliofemoral
(transobturator)
12 hours Cardia
FPV, Femoropopliteal vein, GAH, graft-associated hemorrhage; ASA, Amefield, ongoing and uncontrolled infection, poor woundhealing secondary to severe malnutrition, immunocompro-
mised state, and in some cases, irradiated tissues as well as
the potential for enzymatic digestion from saliva and bac-
terial proteases.
All technical causes were preventable and due to inad-
equate ligation of FPV side branches. In reviewing the
details of these cases, it is noteworthy that a slipped or
“popped” tie was found on re-exploration. More precisely,
the tie became dislodged from a large side branch that was
typically broad-based and short, such that the tie had an
attenuated hold or purchase on the side branch. Because of
the large diameter of the FPV, the wall tension when
exposed to arterial pressure is much greater than a compa-
rable side branch on a greater saphenous vein graft, and
attention to this seemingly small detail is important, even
for experienced surgeons.
Based on this experience, we have modified our tech-
nique as follows: (1) all side branches 1 mm in diameter
are doubly ligated, (2) on side branches  3 mm in diam-
eter a suture ligature is placed as the second, outer ligature,
and (3) side-branch division is carried out at least 2 mm
beyond the outer ligature to provide adequate hold or
purchase that may compensate for the greater wall tension
of these large-caliber grafts. Since making these technical
modifications, we have not encountered this complication.
The cases of GAH due to graft disruption from ongo-
ing infection, malnutrition, and poor healing are more
problematic. Patients with infected aortic prostheses are
commonly elderly, chronically ill, deconditioned, and mal-
nourished, with multiple serious medical comorbidities.
However, the patients in the present report were at the
extreme end of this spectrum in that most had polymicro-
bial infections and a prolonged course of medical and
surgical treatment for their graft infections before definitive
treatment with graft excision and FPV graft in situ recon-
struction. Other factors leading to malnutrition, immu-
nocompromised state, and poor healing in the patients
with aortic graft infections included metastatic adenocarci-
noma, lung cancer, myeloproliferative disorder, treatment
with steroids, methotrexate, and gold for severe rheuma-
toid arthritis, and ongoing duodenal leak after repair of an
aortoduodenal fistula.
Three of these patients had infection with Candida
glabrata in addition to bacterial organisms. We have found
this organism to be highly associated with mortality in our
hemorrhage
on
Additional blood
transfusion (units) Outcome
ASA
score
high
a
6 Alive with limb salvage 3
st 4 Alive with limb salvage 3
st 11 Alive with limb salvage 3
Society of Anesthesiologists.iated
ntati
ing t
atom
c arre
c arreoverall series of infected aortic grafts (unpublished obser-
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Age/Sex
Time interval between
diagnosis of aortic
graft infection and
definitive treatment
FPV graft
reconstruction
ASA
score Special risk factors Microbiology
69/F 1 month Aortoiliac 4 1. Active steroid treatment for rheumatoid arthritis.
2. Aortoenteric erosion.
3. Leak from duodenorrhaphy after FPV aortoiliac
reconstruction.
Candida glabrata
and Klebsiella
52/F 2 weeks Aortobifemoral 3 1. Morbid obesity (body mass index  42).
2. Irreversible ischemia in both lower extremities
(refused further bypass surgery and ultimately
required bilateral BKAs).
3. Profound depression with refusal to eat; refused
feeding tube and parental nutrition.
4. Dehiscence femoral wounds.
Candida glabrata
and Escherichia
coli
59/F 10 years (patient had
multiple re-current
infected femoral
anastomotic
aneurysms after
Dacron
aortobifemoral
bypass procedure
and had at least 6
femoral limb
replacements).
Aortobifemoral 3 1. Postoperative delirium and depression.
2. Malnutrition from refusal to eat and refusal of
feeding tube.
3. Failure of primary wound healing.
Candida glabrata
and Bacteroides
fragilis
69/M 7 months Aortobifemoral 4E 1. Initial operation performed for ruptured mycotic
abdominal aortic aneurysm (Dacron graft replace-
ment).
2. Re-explored 1 month later for retroperitoneal
hematoma that grew Staphylococcus epidermidis.
Aortic graft left in place.
Methicillin-resistant
Staphylococcus
epidermidis,
Haemophilus
parainfluenzae,
and
Fusobacterium.
54/F 5 months Aortobifemoral 4 1. Severe rheumatoid arthritis with active treatment
consisting of steroids, gold, and methotrexate.
2. Lung cancer.
3. Aortoenteric fistula.
Candida spp
81/M 7 months Aortobifemoral 4E 1. Chemotherapy for non-Hodgkin’s lymphoma.
2. Myeloproliferative disorder.
3. Metastatic adenocarcinoma to the liver (primary
unknown).
Escherichia coli,
Pseudomonas
aeruginosa, and
Enterococcus.
65/M N/A Carotid 4 1. Status post bilateral radical neck dissection and
laryngectomy for squamous cell carcinoma of the
larynx.
2. Developed carotid blowout from oropharyngeal
leak; first treated with coil embolization of external
carotid artery and covered carotid stent.
3. Developed recurrent oropharyngeal leak and
wound breakdown that was subsequently treated
with carotid resection, FPV graft reconstruction,
and muscle flap coverage.
4. Recurrent oropharyngeal leak with contamination
of vein graft with saliva and oral flora.
Unknown
53/M N/A Carotid 4 1. Extensive squamous cell carcinoma involving the
larynx. At the time of laryngectomy and bilateral
radical neck dissection, carotid involvement was
found. Reconstruction with FPV performed.
2. Developed oropharyngeal leak; vein graft contami-
nated with saliva and oral flora.
Unknown
FPV, Femoropopliteal vein;ASA, American Society of Anesthesiologists;GAH, graft-associated hemorrhage; pRBC, packed red blood cells; BKA, below knee
amputation; AKA, above knee amputation
*Normal albumin range is 3.1 to 4.3 mg/dL
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Albumen
(mg/dL)* Time of Onset GAH
Additional blood
transfusion
requirement
(units pRBC) Site of GAH Outcome
2.4 32 days 17 Dehiscence left iliac limb (Fig 2). Death
1.7 30 days 10 Exposed, infected right distal
limb of aortobifemoral
reconstruction and nonhealing
femoral wound. Anastomotic
dehiscence.
Death
2.1 45 days N/A (patient died
at home)
Femoral wound (probable
femoral anastomotic
dehiscence).
Death
1.9 23 days 8 Left limb blowout at site of
infected retroperitoneal
hematoma.
Alive and well after ligation
left limb and femoral
crossover bypass
2.1 1. At 11 days after operation,
patient had bleeding from
femoral anastomotic disruption
that was repaired.
2. At 180 days after operation,
patient had aortic anastomotic
false aneurysm from ongoing
retroperitoneal infection.
7 Femoral and aortic anastomotic
dehiscences.
Survived aortic ligation
with axillofemoral
bypass, but died later
from lung cancer.
2.1 14 days 6 Left limb of aortofemoral
reconstruction (blowout).
Initially survived ligation of
left limb of aortofemoral
reconstruction but
required AKA and
subsequently died from
multisystem organ
failure.
1.6 2 weeks 12 Dehiscence of carotid FPV
anastomosis.
Ligation of FPV graft and
subsequent stroke.
3.3 6 days 14 Carotid blowout, site unknown. Replaced with another FPV
graft with muscle
coverage and subsequent
survival.
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virulence factors. Rather, we hypothesize that growth of
this organism is reflective of a prolonged treatment course
with multiple antibiotics in a debilitated and immunocom-
promised, chronically septic patient with diminished likeli-
hood of survival.
In our earlier reports, we stated that FPV grafts resist
infection.1,3,6 Clearly, this is not absolute; like all biologic
grafts, FPV grafts can develop disruption with GAH from
ongoing infection, especially when coupled with malnutri-
tion and poor healing ability. We suggest that poor healing
is, in part, etiologic in our cases of GAH with aortic graft
infection because of the debilitated and malnourished state
of these patients and because many had poor wound heal-
ing and anastomotic disruption.
Because of these considerations, we have modified our
standard procedure for FPV graft reconstruction after re-
moval of an infected aortic graft as follows:
1. Intraoperative anastomotic sites (aortic and iliac limb
anastomosis) are covered with omentum whenever pos-
sible. This is particularly important in cases of aortoen-
teric fistula/erosion.
2. We avoid placement of iliac/femoral limbs in grossly
purulent tunnels that are left after removal of infected
limbs. In this circumstance, new retroperitoneal tunnels
are created or FPV grafts are routed around areas of
gross purulence.
3. Consideration is given for prolonged intravenous anti-
biotics (4 to 6 weeks) in patients who are severely
immunocompromised and debilitated, particularly if
graft cultures yield Candida organisms.
4. Femoral anastomotic sites receive complete tissue coverage
after thorough débridement of infected tissues. This may
require muscle flap coverage in some instances.
5. In patients at the extreme, disadvantaged end of the
spectrum of malnutrition, immunocompromised state,
and debilitation, we consider alternative methods to
treat aortic graft infection, especially if multiple medical
comorbidities are present.12,13
Attempts to repair anastomotic dehiscences and perfo-
rations in the patients with poor healing and on-going
infection were, for the most part, futile because of tissue
friability and inability to hold sutures. A simple femoral
anastomotic bleeding site was successfully resutured (pa-
tient 5 in Table III). Another patient had successful FPV
graft replacement (patient 8 in Table III). In both cases,
contamination was minimal or controlled, and the tissues
appeared relatively healthy.
Because we have had excellent results using the FPV
graft for carotid and brachiocephalic reconstructions,4 we
have extended this experience to include carotid replace-
ment after radical head and neck surgery for cancer encas-
ing the carotid artery. Arteriography and balloon occlusion
with nuclear brain imaging are routinely done preopera-
tively to determine absolute requirements for revasculariza-
tion.We have replaced the common and internal carotid
arteries with FPV grafts in nine patients over the past 5
years. GAH from anastomotic dehiscence occurred in two
patients (28%). All patients had oropharyngeal or laryngeal
contamination of the operative field and all underwent
preoperative radiotherapy. However, the two patients with
GAH in this report were unique in that they had uncon-
trolled oropharyngeal salivary leaks that communicated
directly with FPV grafts despite pectoralis major muscle
coverage.
We postulate that enzymatic digestion from salivary
secretions coupled with ongoing infection from oral flora
led to anastomotic disruption and GAH. Because of this
experience, we insist on early exploration to control oro-
pharyngeal leaks, and when this cannot be achieved and the
FPV graft continues to be exposed to salivary secretions,
ligation should be undertaken if preoperative balloon oc-
clusion testing demonstrates a low risk of stroke.
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